MedTrace Logo

Postprandial Inflammation and Fatty Acids

NCT00977262 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2010-04-21

No results posted yet for this study

Summary

The main objective is to elucidate the acute effects of an oral intake of either saturated, monounsaturated or polyunsaturated fatty acids on peripheral blood mononuclear cells (PBMC) whole genome expression of obese and type 2 diabetic obese subjects.

Conditions

Interventions

OTHER

High saturated fat shake

milkshake containing 95 gram of fat, high percentage of saturated fat

OTHER

High monounsaturated fat shake

milkshake containing 95 gram of fat, high percentage of monounsaturated fat

OTHER

High polyunsaturated fat shake

milkshake containing 95 gram of fat, high percentage polyunsaturated fat

Sponsors & Collaborators

  • Dutch Diabetes Research Foundation

    collaborator OTHER

  • Wageningen University

    lead OTHER

Principal Investigators

  • Michael Muller, Prof · Chair Department of Human Nutrition NMG group

  • Lydia A Afman, PhD · Senior scientist department Human Nutrition Wageningen University

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00977262 on ClinicalTrials.gov